Novel anti-inflammatory therapy for Parkinson's disease.
about
Simvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson's diseaseNeuroprotective properties and mechanisms of resveratrol in in vitro and in vivo experimental cerebral stroke modelsSodium phenylbutyrate controls neuroinflammatory and antioxidant activities and protects dopaminergic neurons in mouse models of Parkinson's diseaseChronic apocynin treatment attenuates beta amyloid plaque size and microglial number in hAPP(751)(SL) miceProtective Microglia and Their Regulation in Parkinson's DiseaseIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesBiology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorderFractalkine/CX3CL1 enhances GABA synaptic activity at serotonin neurons in the rat dorsal raphe nucleusInhibition of IkappaB kinase-beta protects dopamine neurons against lipopolysaccharide-induced neurotoxicityVanillic acid attenuates Aβ1-42-induced oxidative stress and cognitive impairment in mice.An Overview of the Protective Effects of Chitosan and Acetylated Chitosan Oligosaccharides against Neuronal Disorders.Ethyl pyruvate protects against hypoxic-ischemic brain injury via anti-cell death and anti-inflammatory mechanisms.Neuroprotective properties of chitosan and its derivatives.Lithium ameliorates lipopolysaccharide-induced microglial activation via inhibition of toll-like receptor 4 expression by activating the PI3K/Akt/FoxO1 pathway.Resveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its anti-inflammatory actions.Effects of naringin, a flavanone glycoside in grapefruits and citrus fruits, on the nigrostriatal dopaminergic projection in the adult brainPresynaptic regulation of dopamine transmission in schizophrenia.HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration.Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease.Activation of BV2 microglia by lipopolysaccharide triggers an inflammatory reaction in PC12 cell apoptosis through a toll-like receptor 4-dependent pathwayProspects of statins in Parkinson diseaseTherapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's diseaseManganese nanoparticle activates mitochondrial dependent apoptotic signaling and autophagy in dopaminergic neuronal cellsPaeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson's disease by activation of adenosine A1 receptorInflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons.NF-κB in Aging and DiseaseCyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases.Inflammation as a causative factor in the aetiology of Parkinson's diseaseQuantitative diffusion tensor imaging detects dopaminergic neuronal degeneration in a murine model of Parkinson's disease.A comparative review of cell culture systems for the study of microglial biology in Alzheimer's disease.A novel compound PTIQ protects the nigral dopaminergic neurones in an animal model of Parkinson's disease induced by MPTP.Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray studyTesting NF-κB-based therapy in hemiparkinsonian monkeysSuppression of nuclear factor-κB activation and inflammation in microglia by physically modified saline.Central dopaminergic system and its implications in stress-mediated neurological disorders and gastric ulcers: short review.Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's diseaseTargeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases.The role of inflammation in CNS injury and diseaseNeurochemical targets and behavioral effects of organohalogen compounds: an update.Resveratrol Produces Neurotrophic Effects on Cultured Dopaminergic Neurons through Prompting Astroglial BDNF and GDNF Release.
P2860
Q24629942-CC87EB98-9062-4483-B369-1F568B564C73Q26824390-C9DCA9FA-BA0F-47B2-AAF4-998B15D96337Q27301885-8CC65766-0B9D-41AC-9C17-C56DE57019F7Q27339727-CADB928B-16CB-4543-87A5-5216839D6CE4Q28079731-981AAD1B-C7C0-41D4-BA39-DDF0EE568261Q28388335-642D64B8-20DE-4A42-9E17-F5071A788478Q28392275-7375C438-1F8A-4712-96B8-96DFD94C9035Q28570501-D7C9FC8D-BFB0-449C-A6A0-BC4FCA8A003CQ28577454-3218A2CF-3C39-495D-A6E2-3CD36EC7AB1DQ30835280-FE069F61-F825-4EB8-9562-E64FF9B35D70Q33612147-2E9B16F3-A341-4E7C-9B37-AEA8B81B81F4Q33665291-9B055C24-936F-4ADF-81B4-B0117C7878B8Q34061851-187C05FD-F190-4B19-9589-62A33E3B67BDQ34108882-1F53CEA2-311F-492B-9B50-A76855A36462Q34127988-FFD03AA7-3D22-4679-8D80-891D011DF2FBQ34319584-140E2581-8968-4238-9531-771BD6C37D94Q34415890-CA65DCB5-EE64-4894-8E72-C80CA796919BQ34615988-81FA7D0A-CF7B-4CFD-9EB1-1AA7D105C361Q35044751-5DF4E6A9-28AE-4C9F-BC93-B27E3F86CCAFQ35078808-6C67D9DE-52FE-4D00-9810-0E553A5E1DFDQ35094028-B780A1BD-1D4B-4232-A3BC-BE90C5436C6AQ35320917-6D04F21D-F4EE-4EDE-AB85-19237958DB2CQ35489449-70EC0A35-EF7E-4376-859D-12B02D41A62EQ35545909-03481A97-9A71-44C2-8433-FF73959E7145Q35687315-A87491C4-AA85-43D8-9AF9-AFACACBD84CBQ35806773-948FC827-37C6-4698-BFF4-0E64609EA561Q35903755-395E6B7E-116F-4B3A-9983-BB4F9328D00EQ36052641-D6741043-6402-458B-8CC0-18D54A477A67Q36088218-A880BEB3-35D5-4B6E-87BE-67F99C7C642FQ36125335-2C1E25E0-93C7-4A97-9FB9-42250114F0C7Q36147318-7C9A5BE1-8F28-4D0E-A2C5-21CBC0D9692CQ36164195-B7481E91-7E8F-45B7-AD34-D608FE1D0AB4Q36166141-F87E1F4C-97E0-4E7B-B52E-DF340AB1E68CQ36215873-8E7D49AF-374C-4A0C-97B8-9FFECB53E552Q36253550-7E5B2A86-3BA2-40B1-917A-139F369385D6Q36276997-BCD22535-4D5B-42A7-8F74-DB7FC5988423Q36330960-ADE2F9A9-1F32-4319-B1B4-C6492F9CD199Q36364424-008FFF37-54FE-49D3-8139-65C73F9DE9FAQ36473995-06E68DD8-24B4-4616-B3D7-BD454B99F802Q36477181-ACF2D22E-5BA6-4BA7-AF4C-F4B965DA7C63
P2860
Novel anti-inflammatory therapy for Parkinson's disease.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Novel anti-inflammatory therapy for Parkinson's disease.
@ast
Novel anti-inflammatory therapy for Parkinson's disease.
@en
type
label
Novel anti-inflammatory therapy for Parkinson's disease.
@ast
Novel anti-inflammatory therapy for Parkinson's disease.
@en
prefLabel
Novel anti-inflammatory therapy for Parkinson's disease.
@ast
Novel anti-inflammatory therapy for Parkinson's disease.
@en
P2093
P1476
Novel anti-inflammatory therapy for Parkinson's disease
@en
P2093
Hui Ming Gao
Wangqin Zhang
P304
P356
10.1016/S0165-6147(03)00176-7
P577
2003-08-01T00:00:00Z